Zuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Diethylstilbestrol | The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Zuretinol acetate. |
| Estradiol | The therapeutic efficacy of Estradiol can be decreased when used in combination with Zuretinol acetate. |
| Ethinylestradiol | The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Zuretinol acetate. |
| Mestranol | The therapeutic efficacy of Mestranol can be decreased when used in combination with Zuretinol acetate. |
| Estradiol cypionate | The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Zuretinol acetate. |
| Estradiol valerate | The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Zuretinol acetate. |
| Estetrol | The therapeutic efficacy of Estetrol can be decreased when used in combination with Zuretinol acetate. |
| Desogestrel | The therapeutic efficacy of Desogestrel can be decreased when used in combination with Zuretinol acetate. |
| Megestrol acetate | The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Zuretinol acetate. |
| Levonorgestrel | The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Zuretinol acetate. |
| Medroxyprogesterone acetate | The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Zuretinol acetate. |
| Norethisterone | The therapeutic efficacy of Norethisterone can be decreased when used in combination with Zuretinol acetate. |
| Ethynodiol diacetate | The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Zuretinol acetate. |
| Norgestimate | The therapeutic efficacy of Norgestimate can be decreased when used in combination with Zuretinol acetate. |
| Drospirenone | The therapeutic efficacy of Drospirenone can be decreased when used in combination with Zuretinol acetate. |
| Cyproterone acetate | The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Zuretinol acetate. |
| Gestodene | The therapeutic efficacy of Gestodene can be decreased when used in combination with Zuretinol acetate. |
| Hydroxyprogesterone caproate | The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Zuretinol acetate. |
| Dienogest | The therapeutic efficacy of Dienogest can be decreased when used in combination with Zuretinol acetate. |
| Norethynodrel | The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Zuretinol acetate. |
| Norgestrel | The therapeutic efficacy of Norgestrel can be decreased when used in combination with Zuretinol acetate. |
| Gestrinone | The therapeutic efficacy of Gestrinone can be decreased when used in combination with Zuretinol acetate. |
| Lynestrenol | The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Zuretinol acetate. |
| Chlormadinone | The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Zuretinol acetate. |
| Norgestrienone | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Zuretinol acetate. |
| Quingestanol | The therapeutic efficacy of Quingestanol can be decreased when used in combination with Zuretinol acetate. |
| Demegestone | The therapeutic efficacy of Demegestone can be decreased when used in combination with Zuretinol acetate. |
| Nomegestrol acetate | The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Zuretinol acetate. |
| Vitamin A | The risk or severity of adverse effects can be increased when Vitamin A is combined with Zuretinol acetate. |
| Valproic acid | Valproic acid may increase the Pseudotumor Cerebri activities of Zuretinol acetate. |
| Doxycycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Doxycycline. |
| Clomocycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Clomocycline. |
| Tigecycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Tigecycline. |
| Oxytetracycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Oxytetracycline. |
| Demeclocycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Demeclocycline. |
| Tetracycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Tetracycline. |
| Metacycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Metacycline. |
| Minocycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Minocycline. |
| Rolitetracycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Rolitetracycline. |
| Sarecycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Sarecycline. |
| Eravacycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Eravacycline. |
| Omadacycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Omadacycline. |
| Penimepicycline | The risk or severity of pseudotumor cerebri can be increased when Zuretinol acetate is combined with Penimepicycline. |
| Methotrexate | The risk or severity of adverse effects can be increased when Methotrexate is combined with Zuretinol acetate. |
| Lymecycline | The risk or severity of pseudotumor cerebri can be increased when Lymecycline is combined with Zuretinol acetate. |
| Palovarotene | The risk or severity of adverse effects can be increased when Zuretinol acetate is combined with Palovarotene. |